Olanzapine versus droperidol for the treatment of primary headache in the emergency department

Academic Emergency Medicine

Volumn 15, Issue 9, 2008, Pages 806-811

  Hill, Chandler H ^a   Miner, James R ^a   Martel, Marc L ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Droperidol; Emergency department; Headache; Migraine; Olanzapine; Treatment

Indexed keywords

DROPERIDOL; OLANZAPINE;

ADULT; AKATHISIA; ANALGESIA; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; HEALTH PLAN EMPLOYER DATA AND INFORMATION SET; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN; PRIMARY HEADACHE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; BENZODIAZEPINES; CHI-SQUARE DISTRIBUTION; DOPAMINE ANTAGONISTS; DROPERIDOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 56849095726     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00197.x     Document Type: Article

References (28)

1. Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; (386):1-32.
2. Saper JR. Headache disorders. Med Clin North Am. 1999; 83:663-90.
3. Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary headaches. Neurology. 2004; 63:427-35.
4. Lipton RB, Stewart WF, Cady R, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000; 40:783-91.
5. Miner JR, Fish SJ, Smith SW, Biros MH. Droperidol vs. prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001; 8:873-9.
6. Miner JR, Smith SW, Moore J, Biros M. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med. 2007; 25:60-4.
7. Trainor A, Miner JR. Pain treatment and relief among patients with primary headache subtypes in the ED. Am J Emerg Med. 2008; in press.
8. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. Br Med J. 2004; 329:1369-73.
9. Friedman BW, Corbo J, Lipton RB, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005; 64:463-8.
10. Friedman BW, Esses D, Solorzano C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2007; [Epub ahead of print].
11. Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1994; 24:237-41.
12. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996; 14:262-4.
13. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001; 41:638-45.
14. Richman PB, Reischel U, Ostrow A, et al. Droperidol for acute migraine headache. Am J Emerg Med. 1999; 17:398-400.
15. Vinson DR, Hurtado TR, Vandenberg JT, Banwart L. Variations among emergency departments in the treatment of benign headache. Ann Emerg Med. 2003; 41:90-7.
16. Chambers RA, Druss BG. Droperidol: efficacy and side effects in psychiatric emergencies. J Clin Psychiatry. 1999; 60:664-7.
17. Chase PB, Biros MH. A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population. Acad Emerg Med. 2002; 9:1402-10.
18. Martel M, Sterzinger A, Miner J, Clinton J, Biros M. Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam. Acad Emerg Med. 2005; 12:1167-72.
19. Nuttall GA, Eckerman KM, Jacob KA, et al. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population? Anesthesiology. 2007; 107:531-6.
20. Leelahanaj T, Kongsakon R, Netrakom P. A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis. J Med Assoc Thai. 2005; 88(Suppl 3):S43-52.
21. Rozen TD. Olanzapine as an abortive agent for cluster headache. Headache. 2001; 41:813-6.
22. Rozen TD. New treatments in cluster headache. Curr Neurol Neurosci Rep. 2002; 2:114-21.
23. Navari RM, Einhorn LH, Passik SD, et al. A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer. 2005; 13:529-34.
24. Silberstein SD, Peres MF, Hopkins MM, Shechter AL, Young WB, Rozen TD. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache. 2002; 42:515-8.
25. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry. 1989; 154:672-6.
26. International Headache Classification Committee. ICD-10 Guide for Headaches. Cephalalgia. 1997; 19:1-82.
27. Miner JR, Fringer R, Siegel T, Gaetz A, Ling L, Biros M. Serial bispectral index scores in patients undergoing observation for sedative overdose in the emergency department. Am J Emerg Med. 2006; 24:53-7.
28. Citrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry. 2007; 68:1876-85.